書籍詳細

特別講演 I

P.5 掲載の参考文献

• 1) 岡本尚:活性酸素による遺伝子発現制御. 活性酸素とシグナル伝達(井上正康・編), 講談社, 東京, 1996, pp.37-46.

• 2) Holmgren A:Thioredoxin. Ann. Rev. Biochem. 54:237-271, 1985.
  pubmed

• 3) Holmgren A:Thioredoxin and glutaredoxin systems. J. Biol. Chem. 264:13963-13966, 1989.
  pubmed

• 4) Baeuerle PA:The inducible transcription activator NF-kappa B:regulation by distinct protein sub-units. Biochim. Biophys. Acta 1072:63-80, 1991.

• 5) Baeuerle PA and Henkel T:Function and activation of NF-kappa B in the immune system. Ann. Rev. Immunol. 12:141-179, 1994.

• 6) Thanos D and Maniatis T:NF-kappa B:a lesson in family values. Cell 80:529-532, 1995.
  pubmed

• 7) Los M, Schenk H, Hexel K, et al:IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14:3731-3740, 1995.
  pubmed

• 8) Tagaya Y, Okada M, Sugie K, et al:IL-2 receptor (p55) /Tac-inducing factor. Purification and characterization of adult T cell leukemia-derived factor. J.lmmunol. 140:2614-2621, 1988.
  pubmed

• 9) Qin J, Clore GM, Kennedy WM, et al:Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF kappa B. Structure 3:289-297, 1995.

• 10) Okamoto T, Ogiwara H, Hayashi T, et al:Human thioredoxin/adult T-cell leukemia-derived factor (TRX/ADF) activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. Int. Immunol. 4:811-819, 1992.
  pubmed

• 11) Hayashi T, Ueno Y and Okamoto T:Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268:11380-11388, 1993.
  pubmed

• 12) Frame MC, Wilkie NM, Darling AJ, et al:Regulation of AP-1/DNA complex formation in vitro. Oncogene 6:205-209, 1991.
  pubmed

• 13) Myrset AH, Bostad A, Jamin N, et al:DNA and redox state induced conformational changes in the DNA-binding domain of the Myb oncoprotein. EMBO J. 12:4625-4633, 1993.
  pubmed

• 14) Kambe F, Nomura Y, Okamoto T, et al:Redox regulation of thyroid-transcription factors pax-8 and TTF-1 in vitro. Mol. Endocrinol. 10:801-812, 1996.
  pubmed

• 15) Nakamura K, Hori T, Sato N, et al:Redox regulation of a src family protein tyrosine kinase p56lck in T cells.Oncogene 8:3133-3139, 1993.

• 16) Okamoto T, Matsuyama T, Mori S, et al:Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha. AIDS Res. Hum. Retroviruses 5:131-138, 1989.
  pubmed

• 17) Hayashi T, Sekine T and Okamoto T:Identifiction or a new serine kinase that activates NF-κB by direct phosporylation. J. Biol. Chem. 268:26790-26795, 1993.

• 18) Naumann M and Scheidereit C:Activation of NF-kappa B in vivo is regulated by multiple phosphorylations. EMBO J. 13:4597-4607, 1994.
  pubmed

• 19) Cao Z, Henzel WJ and Gao X:IRAK:a kinase associated with the interleukin-1 receptor. Science 271:1128-1131, 1996.

• 20) Ghosh G, Van Duyne G, Ghosh S, et al:Structure of NF-kappa B p50 homodimer bound to a kappa B site. Nature 373:303-310, 1995.
  pubmed

• 21) Muller CW, Rey FA, Sodeoka M, et al:Structure of the NF-kappa B p50 homodimer bound to DNA. Nature 373:311-317, 1995.
  pubmed

• 22) Yang JP, Merin JP, Nakano T, et al:Inhibition of the DNA-binding activity of NF-κB by gold compounds in vitro. FEBS Lett. 361:89-96, 1995

• 23) Schreck R, Rieber P and Baeuerle PA:Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:2247-2258, 1991.
  pubmed

• 24) Tozawa K, Sakurada S, Kohri K, et al:Effects of anti-nuclear factor κB reagents in blocking adhesion of human cancer cell to nasular endothelial cells. Cancer Res. 55:4162-4167, 1995.

• 25) Sakurada S, Kato T and Okamoto T:Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblats and inhibition by N-acetyl-L-cysteine and aspirin. Int. Immunol. 8:1483-1493, 1996.

P.15 掲載の参考文献

• 1) 神奈木玲児:癌の転移と細胞接着分子 "臨床医のための実験医学シリーズ. 細胞接着分子と関連疾患"(神奈木玲児・編), 羊土社, 東京, 1994, pp.24-36.

• 2) Kannagi R:Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj. J. 14:577-584, 1997.
  pubmed

• 3) 桐山幸三, 渡辺 正:癌の浸潤, 転移と糖鎖抗原. "最新医学からのアプローチ:複合糖質" (神奈木玲児・編), メジカルビュー社, 東京, 1994, pp.67-75.

• 4) Shimono R, Mori M, Akazawa K, et al:Immunohistochemical expression of carbohydrate antigen 19-9 in colorectal carcinoma. Am. J. Gastroenterol, 89:101-105, 1994.
  pubmed

• 5) Nakayama T, Watanabe M, Katsumata T, et al:Expression of sialyl Lewis a as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 75:2051-2056, 1995.
  pubmed

• 6) Narita T, Funahashi H, Satoh Y, et al:Association of expression of blood group-related carbohydrate antigens with prognosis in breast cancer. Cancer 71:3044-3053, 1993.
  pubmed

• 7) Biancone L, Araki M, Araki K, et al:Redirection of tumor metastasis by expression of E-selectin in vivo. J. Exp. Med. 183:581-587, 1996.
  pubmed

• 8) Saiki I, Koike C, Obata A, et al:Functional role of sialyl Lewis X and fibronectin-derived RGDS peptide analogue on tumor-cell arrest in lungs followed by extravasation. Int. J. Cancer 65:833-839, 1996.
  pubmed

• 9) Oku N, Koike C, Tokudome Y, et al:Application of liposomes for cancer metastasis. Adv. Drug Deliv. Rev. 24:215-223, 1997.

• 10) Nakashio T, Narita T, Sato M, et al:The association of metastasis with the expression of adhesion molecules in cell lines derived from human gastric cancer. Anticancer Res. 17:293-299, 1997.
  pubmed

• 11) Koprowski H, Herlyn M, Steplewski Z, et al:Specific antigen in serum of patients with colon carcinoma. Science 212:53-55, 1981.
  pubmed

• 12) Kannagi R, Fukushi Y, Tachikawa T, et al:Quantitative and qualitative characterization of cancer-associated serum glycoprotein antigens expressing fucosyl or sialosyl-fucosyl type 2 chain polylactosamine. Cancer Res. 46:2619-2626, 1986.
  pubmed

• 13) Lowe JB, Stoolman LM, Nair RP, et al:ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA. Cell 63:475-484, 1990.
  pubmed

• 14) Takada A, Ohmori K, Takahashi N, et al:Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem. Res. Commun. 179:713-719, 1991.
  pubmed

• 15) Takada A, Ohmori K, Yoneda T, et al:Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 53:354-361, 1993.
  pubmed

• 16) Narita T, Kawakami-Kimura N, Kasai Y, et al:Induction of E-selectin expression on vascular endothelium by digestive system cancer cells. J. Gastroenterol. 31:299-301, 1996.

• 17) Kawakami-Kimura N, Narita T, Ohmori K, et al:Involvement of hepatocyte growth factor in increased integrin expression on HepG2 cells triggered by adhesion to endothelial cells. Br. J. Cancer 75:47-53, 1997.
  pubmed

• 18) Sato M, Narita T, Kawakami-Kimura N, et al:Increased expression of integrins by heparin-binding EGF like growth factor (HB-EGF) in human esophageal cancer cell. Cancer Lett. 102:183-191, 1996.
  pubmed

• 19) Narita T, Kawakami-Kimura N, Sato M, et al:Alteration of integrins by heparin-binding EGF-like growth factor (HB-EGF) in human breast cancer cells. Oncology 53:374-381, 1996.
  pubmed

• 20) 神奈木玲児, 木村尚子:血管新生に関与するセレクチンとインテグリン. 臨床免疫 29 (3):378-384, 1997.

• 21) 神奈木玲児:細胞接着分子としての糖鎖抗原. 日外会誌 97:131-139, 1996.

• 22) Holmes EH, Ostrander GK and Hakomori S:Enzymatic basis for the accumulation of glycolipids with X and dimeric X determinants in human lung cancer cells (NCI-H69). J. Biol. Chem. 260:7619-7627, 1985.
  pubmed

• 23) Holmes EH, Ostrander GK and Hakomori S:Biosynthesis of the sialyl-Lex determinant carried by type 2 chain glycosphingolipids (IV3NeuAcIII3 FucnLc4, VI3NeuAcV3FucnLc6, and VI3NeuAcIII3V3 Fuc2nLc6) in human lung carcinoma PC9 cells. J. Biol. Chem. 261:3737-3743, 1986.

• 24) Kukowska-Latallo JF, Larsen RD, Nair RP, et al:A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α (1,3/1,4) fucosyltransferase. Genes Dev. 4:1288-1303, 1990.

• 25) Lowe JB, Kukowska-Latallo JF, Nair RP, et al:Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis x and VIM-2 epitopes but not ELAM-1-dependent cell adhesion.J.Biol.Chem. 266:17467-17477, 1991.

• 26) Goelz SE, Hession C, Goff D, et al:ELFT:a gene that directs the expression of an ELAM-1 ligand. Cell 63:1349-1356, 1990.
  pubmed

• 27) Weston BW, Smith PL, Kelly RJ, et al:Molecular cloning of a fourth member of a human α (1,3) fucosyltransferase gene family. Multiple homologous sequences that determine expression of the Lewis x, sialyl Lewis x, and difucosyl sialyl Lewis x epitopes. J. Biol. Chem. 267:24575-24584, 1992.

• 28) Weston BW, Nair RP, Larsen RD, et al:Isolation of a novel human α (1,3) fucosyltransferase gene and molecular comparison to the human Lewis blood group α (1,3/1,4) fucosyltransferase gene. Syntenic, homologous, nonallelic genes encoding enzymes with distinct acceptor substrate specificities. J. Biol. Chem. 267:4152-4160, 1992.

• 29) Koszdin KL and Bowen BR:The cloning and expression of a human α-1,3 fucosyltransferase capable of forming the E-selection ligand. Biochem. Biophys Res. Commum. 187:152-157, 1992.

• 30) Akamatsu S, Yazawa S, Tachikawa T, et al:α 2→3 Sialyltransferase associated with the synthesis of CA 19-9 in colorectal tumors.Cancer 77 (Suppl.):1694-1700, 1996.

• 31) Dohi T, Hashiguchi M, Yamamoto S, et al:Fucosyltransferase-producing sialyl Lea and sialyl Lex carbohydrate antigen in benign and malignant gastrointestinal mucosa. Cancer 73:1552-561, 1994.
  pubmed

• 32) Yago K, Zenita K, Ginya H, et al:Expression of α (1,3) fucosyltransferases which synthesize sialyl Lex and sialyl Lea, the carbohydrate ligands for E- and P-selectins, in human malignant cell lines. Cancer Res. 53:5559-5565, 1993.

• 33) Ito H, Hiraiwa N, Sawada-Kasugai M, et al:Altered mRNA expression of specific molecular species of fucosyl-and sialyltransferases in human colorectal cancer tissues.Int.J.Cancer 71:556-564, 1997.
  pubmed

• 34) Hakomori S, Ichikawa D, Withers DA, et al:Expression vs. deletion of histo-blood group A and B genes in human tumors as related to malignancy. International Symposium on Glycosyltransferases and Cellular Communication (Organized by N. Taniguchi) , Osaka, Japan, 1997, Abstract, p.71.

• 35) 澤田正志, 森谷節子, 矢守隆夫・他:マウス結腸癌colon26細胞の転移能に関与するシアリダーゼの検索. 第6回がん転移研究会, 広島, 1997, 第6回がん転移研究会アブストラクト, p.60.

• 36) Ohmori K, Yoneda T, Shigeta K, et al:Sialyl SSEA-1 antigen as a carbohydrate marker of human natural killer cells and immature lymphoid cells. Blood 74:255-261, 1989.
  pubmed

• 37) Ohmori K, Takada A, Ohwaki I, et al:A distinct type of sialyl Lewis X antigen defined by a novel monoclonal antibody is selectively expressed on helper memory T cells. Blood 82 (9):2797-2805, 1993.
  pubmed

• 38) Furukawa Y, Tara M, Ohmori K, et al:Variant type of sialyl Lewis X antigen expressed on adult T cell leukemia cells is associated with skin involvement. Cancer Res. 54:6533-6538, 1994.
  pubmed

• 39) Natsuka S, Gersten KM, Zenita K, et al:Molecular cloning of a cDNA encoding a novel human leukocyte α 1,3-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant.J.Biol.Chem. 269:16789-16794, 1994.

• 40) Sasaki K, Kurata K, Funayama K, et al:Expression cloning of a novel α 1,3-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes. J. Biol. Chem. 269:14730-14737, 1994.

• 41) Hiraiwa N, Dohi T, Kawakami-Kimura N, et al:Suppression of sialyl Lewis X expression and E-selectin-mediated cell adhesion in cultured human lymphoid cells by transfection of antisense cDNA of an α 1→3 fucosyltransferase (Fuc-T VII). J. Biol. Chem. 271:31556-31561, 1996.

• 42) Ohtani K, Nakamura M, Saito S, et al:Electroporation:application to human lymphoid cell lines for stable introduction of a transactivator gene of human T-cell leukemia virus type I. Nucleic Acids Res. 17:1589-1604, 1989.
  pubmed

• 43) Nagata K, Ohtani K, Nakamura M, et al:Activation of endogenous c-tos proto-oncogene expression by human T-cell lukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat.J.Virol. 63:3220-3226, 1989.

• 44) Ohtani K, Nakamura M, Saito S, et al:Identification of two distinct elements in the long terminal repeat of HTLV-I responsible for maximum gene expression. EMBO J. 6:389-395, 1987.

• 45) Hiraiwa N, Hiraiwa M and Kannagi R:Human T-cell leukemia virus-1 encoded Tax protein transactivates α 1→3 fucosyltransferase Fuc-T VII, which synthesizes sialyl Lewis X, a selectin ligand expressed on adult T-cell leukemia cells. Biochem. Biophys Res. Commun. 231:183-186, 1997.

• 46) Wagner S and Green MR:HTLV-I tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262:395-399, 1993.
  pubmed

• 47) Brauweiler A, Garl P, Franklin AA, et al:A molecular mechanism for human T-cell leukemia virus latency and tax transactivation. J.Biol.Chem. 270:12814-12822, 1995.
  pubmed

• 48) Yin MJ and Gaynor RB:Complex formation between CREB and tax enhances the binding affinity of CREB for the human T-cell leukemia virus type 1 21-base-pair repeats. Mol. Cell Biol. 16:3156-3168, 1996.
  pubmed

• 49) Kwok RPS, Laurance ME, Lundblad JR, et al:Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380:642-646, 1996.

P.21 掲載の参考文献

• 1) Warren JR and Marshall BJ:Unidentified curved bacilli on gastric epithelium in active chronic gastritis, Lancet ii:1273-1275, 1983.

• 2) 松井邦泰, 田村和也, 寺田昭・他:Campylobacter pyloriと胃疾患. 日消病会誌 84:1864, 1987.

• 3) Tsujii M, Kawano S, Tsuji S, et al:Mechanism of gastric mucosal damage induced by ammonia. Gastroenterology 102:1881-1888, 1992.
  pubmed

• 4) Kawano S, Tsujii M, Nagano K, et al:Different effect of Helicobacter pylori on the human gastric antral and body mucosal intracellular mucin. Scand J. Gastroenterol. 25:997-1003, 1990.
  pubmed

• 5) Kawano S, Tsujii M, Tsuji S, et al:Effects of ammonia on Helicobacter pylori-associated gastric disease. Eur. J. Gastroenterol. Hepatol, 5 (Suppl.1):S29-S33, 1993.

• 6) Tsujii M, Kawano S, Tsuji S, et al:Mechanism for ammonia-induced promotion of gastric carcinogenesis in rats. Carcinogenesis 16:563-566, 1995.
  pubmed

P.26 掲載の参考文献

• 1) Brown JF, Hanson PJ and Whittle BJR:Nitric oxide donors increase mucus gel thickness in rat stomach. Eur. J. Pharmacol. 223:103-104, 1992.

• 2) Brown JF, Keates AC, Hanson PJ, et al:Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells. Am.J.Physiol. 265:G 418-G422, 1993.

• 3) Price KJ, Hanson PJ and Whittle BJR:Stimulation by carbachol of mucus gel thickness in rat stomach involves nitric oxide. Eur. J. Pharmacol. 263:199-202, 1994.

• 4) Clementi E, Riccio M, Sciorati C, et al:The type 2 ryanodine receptor of neurosecretory PC12 cells is activated by cyclic ADP-ribose. ROLE OF THE NITRIC OXIDE/cGMP PATHWAY. J. Biol. Chem. 271 (30):17739-17745, 1996.
  pubmed

• 5) Brown JF, Tepperman BL, Hanson PJ, et al:Differential distribution of nitric oxide synthase between cell fraction isolated from the rat gastric mucosa. Biochem. Biophys. Res. Commun 184 (2):680-685, 1992.
  pubmed

• 6) Galione A, Lee HC and Busa WB:Ca2+-induced Ca2+ release in sea urchin egg homogenates;modulation by cyclic ADP-ribose. Science. 253:1143-1146, 1991.
  pubmed

• 7) Galione A, White A, Willmott N, et al:cGMP mobilizes intracellular Ca2+ in sea urchin eggs by stimulating cyclic ADP-ribose synthesis. Nature 365:456-459, 1993.
  pubmed

• 8) Ikei N, Busik J,Habara Y,et al:Competitive inhibition by procaine of carbachol-induced stimulus- secretion cupling in rat pancreatic acini. Br. J. Pharmacol. 110:603-608, 1993.

P.29 掲載の参考文献

• 1) Kanno Y and Matsui Y:Cellular uncoupling in cancerous stomach epithelium. Nature 218:775-776, 1968.
  pubmed

• 2) Kyoi T, Ueda F, Kimura K, et al:Development of gap junctions between gastric surface mucosa cells during cell maturation in rats. Gastroenterology 102 :1930-1935, 1992.
  pubmed

• 3) Mine T, Yasuda H, Kataoka A, et al:Human chronic gastric ulcer and connexin. J. Clin. Gastroenterol. 21 S104-S107, 1995.

• 4) Matesic DF, Rupp HL, Bonney WJ, et al:Changes in gap-junction permeability, phosphorylation, and numbers mediated by phorbol ester and non-phorbol-ester tumor Promoters in rat liver epithelial cells. Mol. Carcinog. 10:226-236, 1994,
  pubmed

• 5) Krutovskikh VA, Mazzoleni G, Mironov N, et al:Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein iocalization but not gene mutation of connexin 32. lnt. J. Cancer 56:87-94, 1994.

• 6) Correa P, Malnizel W, Cuello C, et al:Gastric pre- cancerous process in a high risk population:cross-sectional studies. Cancer Res. 50:4731-4736, 1990.

P.33 掲載の参考文献

• 1) 野口哲也, 笹野公伸, 加藤勝章・他:ラット酢酸潰瘍の治癒過程におけるTGF-αとEGFR発現の免疫組織学的検討. 日消病会誌 91:568, 1994.

• 2) Brzozowski T, Majka J, Garlicki J, et al:Role of polyamines and Prostaglandins in gastroprotective action of epidermal growth factor against ethanol injury. J. Clin. Gastroenterol. 13:S98-S102, 1992.

• 3) Polk WH, Dempsey PJ, Russell WE, et al:Increased production of transforming growth factor α following acute gastric injury. Gastroenterology 102:1467-1474, 1992.

• 4) 中島典子, 桑山 肇:胃粘膜上皮細胞回転と粘膜修復. G.I.Research 1 (6):699-704.1993.
  Medical*Online

• 5) Tunio AM, Holton J and Hobsley M:Gastric juice epidermal growth factor concentration and Helicobacter pylori in patients with duodenal ulcer. Br.J.Surg. 82:1204-1206, 1995.
  pubmed

P.38 掲載の参考文献

• 1) Falchuk KR and Conlin D:The intestinal and liver complications of diabetes mellitus. Adv. Intern. Med. 38:269-286, 1993.
  pubmed

• 2) O'Reilly D and Long RG:Diabetes and the gastrointestinal tract. Dig. Dis. Sci. 5:57-64, 1987.

• 3) Takeuchi K, Ueshima K, Ohuchi T, et al:Induction of gastric lesions and hyperglcemic response by food deprivation in streptozotocin-diabetic rats. Dig.Dis.Sci. 39:626-634, 1994.
  pubmed

• 4) Hamlet A, Jonson C and Fandriks L:The mediation of increased alkaline secretion in response to 10 mM HCI in the anesthetized rat.Acta Physiol.Scand. 146:519-525, 1992.

• 5) Algazi MC, Chen HS, Koss MA, et al:Effect of VIP antagonist on VIP-, PGE2-, and acid-stimulated duodenal bicarbonate secretion. Am. J. Physiol. 256:G833-G836, 1989.
  pubmed

• 6) Takeuchi K, Matsumoto J, Ueshima K, et al:Role of capsaicin-senstive afferent neurons in alkaline secretory response to luminal acid in the rat duodenum. Gastroenterology 101:954-961, 1991.

• 7) Lincoln J, Bokor JT, Crowe R, et al:Myenteric plexus in streptozotocin-treated rats:Neurochemical and histochemical evidence for diabetic neurophathy in the gut. Gastroenterology 86:654-661, 1984.

• 8) Belai A and Burnstock G:Selective damage of intrinsic calcitonin gene-related peptide-like immunoreactive enteric nerve fibers in streptozotocin-induced diabetic rats. Gastroenterology 92:730-734, 1987.
  pubmed

• 9) Takeuchi K, Furukawa O, Tanaka H, et al:A new model of duodenal ulcers induced by rats by indomethacin plus histamine. Gastroenterology 90:636-645, 1986.

• 10) Isenberg JI, Selling JA, Hogan DL, et al:Impaired proximal duodenal mucosal bicarbonate secretion in patients with duodenal ulcer. New Engl.J.Med. 316:374-379, 1987.
  pubmed

P.42 掲載の参考文献

• 1) Greber GM, Wukich DK, Cafferty PJ, et al:Changes in peripheral serum creatine phosphokinase (CPK) and lactate dehydrogenase (LDH) in acute experimental colonic infarction. Ann. Surg. 194:708-715, 1981.

• 2) 前田壽哉, 湯浅英樹, 有村俊寛・他:絞扼性イレウス早期鑑別診断における血清creatine phosphokinase値の有用性. 日消外会誌 26:1007-1012, 1993.

• 3) 和田哲成, 長畑洋司, 安積靖友・他:複雑性イレウスにおける血液凝固線溶系因子の検討. 神戸大医紀 57:1-9, 1996.

• 4) Shakir M, Margolis S, Baylin S, et al:Localization of Histaminase (Diamine oxidase) in rat small intestinal mucosa:site of release by heparin. Biochem. Pharmacol. 26:2343-2347, 1977.

• 5) Agostino L, Daniel B, Pignata S, et al:Modifications in enterocyte diamine oxidase distribution induced by heparin in the rat. Biochem. Pharmacol. 38:47-49, 1994.

• 6) 和田哲成, 長畑洋司, 安積靖友・他:ラットにおける新しいイレウスモデルの作成. 日消外会誌 27:1870, 1994.

• 7) Takagi K, Nakao M, Ogura Y, et al:Sensitive colorimetric of serum diamine oxidase. Clin. Chimica Acta 226:67-75, 1994.

• 8) Agostino D, Pignata S, Daniele B, et al:Postheparin plasma dianime oxidase values in the follow up of patients with small bowel Crohn disease. Gut 32:932-935, 1991.

P.50 掲載の参考文献

• 1) Alter M, Margolis H, Krawczynski K, et al:The natural history of community-acquired hepatitis C in the United States. N. Engl. J. Med. 327:1899-1905, 1992.
  pubmed

• 2) Hwang S, Lo SY, Ou JH, et al:Detection of cellular proteins and viral core protein interacting with the 5'-untranslated region of hepatitis C virus RNA. J. Biomed. Sci. 2:227-236, 1995.
  pubmed

• 3) Matsumoto M, Hwang S, Jeng KS, et al:Homotypic interaction and multimerization of hepatitis C virus core protein. Virology 218:43-51, 1996.
  pubmed

• 4) Shih CM, Lo S, Miyamura T, et al:Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J. Virol. 67:5823-5832, 1993.

• 5) Ray R, Lagging L, Meyer K, et al:Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 37:209-220, 1995.
  pubmed

• 6) Chien CT, Bartel P, Sternglanz R, et al:The two-hybrid system:a method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl. Acad. Sci. USA 88:9578-9582, 1991.
  pubmed

• 7) Ware C, VanArsdale T, Crowe P, et al:The ligands and receptors of the lymphotoxin system. Curr. Top. Microbiol. Immunol. 198:175-218, 1995.
  pubmed

• 8) Mosialos G, Birkenbach M, Yalamanchili R, et al:The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399, 1995.
  pubmed

• 9) Crowe P, VanArsdale T, Walter B, et al:A lymphotoxin-β-specific receptor. Science 264:707-710, 1994.

• 10) Browing J, Miatkowski K, Sizing I, et al:Signaling through the lymphotoxin β receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med. 183:867-878, 1996.

• 11) Kato N, Ootsuyama Y, Sekiya H, et al:Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J. Virol. 68:4776-4784, 1994.
  pubmed

P.54 掲載の参考文献

• 1) Nonami T, Harada A, Kurokawa T, et al:Advances in Hepatic Resection and Results for Hepatocellular Carcinoma. Semin. Surg. Oncol. 12:183-188, 1996.
  pubmed

• 2) 山中若樹, 岡本英三, 古川一隆・他:表面冷却下肝切除術. 手術 50:621-625, 1996.

• 3) Ion VD, Gregory JB, Charle HL, et al:Hyaluronic Acid Uptake by the Isolated, Perfused Rat Liver:An Index of Hepatic Sinusoidal Endothelial Cell Function. Hepatology 17:266-272, 1993.

• 4) Patricia EG, Barbara K, Steven NL, et al:A New Method to Monitor Kupffer Cell Phagocytosis Continuously in Perfused Rat Liver. Hepatology 13:567-576, 1991.

• 5) 岡上 武, 坂本真一, 伊藤義人:類洞皮細胞の形態と機能. 病理と臨 13:309-314, 1995.

• 6) 内藤 真:Kupffer細胞の形態, 分化と機能. 病理と臨 13:315-323. 1995.

• 7) Wisse E, De Zanger R. B, Chareles K, et al:The Liver Sieve:Considerration concerning the structure and function of Endothelial Fenestrae, the Sinusoidal Wall and the Space od Disse. Hepatology 5:683-692, 1985.

• 8) Inaba H, Araki M, Numai T, et al:Prostaglandin El Attenuates Vasoconstriction Induced by PGE2, PGD2 and Phorbol Myristate in the Perfused. Ratliver. J. Anesth. 7:56-65, 1993.

• 9) Holscher M and Groenewoud AF:Current Status of the HTK Solution of Bretschneider in Organ Preservation. Transplant. Proc. 23:2334-2337, 1991.
  pubmed

• 10) 持田 智, 藤原研司:Kupffer細胞 実験的肝障害における役割. 肝胆膵 24:889-899, 1992.

P.58 掲載の参考文献

• 1) Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20:864-874, 1992.

• 2) Cotran RS and Pober JS:Cytokine-endothelial interactions in inflammation, immunity and vascular injury. J. Am. Soc. Nephrol. 1:225-235, 1990.
  pubmed

• 3) Engelberts I, van Hoff SC, Samyo SK, et al:Generalized inflammation during peritonitis evidenced by intracutaneous E-selectin expression. Clin. lmmunopathol. 65:330-334, 1992.

• 4) Ridings PC, Bloomfield GL, Holloway S, et al:Sepsis-induced acute lung injury is attenuated by selectin blockade following the onset of sepsis. Arch. Surg. 130:1199-1208, 1995.
  pubmed

• 5) 広田昌彦, 野澤文昭, 小川道雄:活性化好中球による組織障害. 臨床免疫 29:1155-1160, 1997.

• 6) 広田昌彦, 小川道雄:外科的侵襲と全身反応, 4. 免疫応答. 日外会誌 97:721-725, 1996.

• 7) Okajima K, Uchiba M, Murakami K, et al:Plasma levels of soluble E-selectin in patients with disseminated intravascular coagulation. Am. J. Hematol. 1997. (in press)

• 8) Newman W, Beal LD, Carson CW, et al:Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J. Immunol. 150:644-654, 1993.

• 9) Ogawa M, Ikei S, Sameshima H, et al:Increased cytokine release in severe acute pancreatitis is closely related to the development of organ failure. In The Immune Consequences of Trauma, Shock and Sepsis Vol. II (edited by Faist E, Baue AE and Schildberg FW), Monduzzi Editore, Bologna, 1996, pp. 332-337.

• 10) Hirota M, Nozawa F, Okabe A, et al:Determination of serum levels of circulating soluble E-selectin in patients after major surgery and in those with acute pancreatitis.In 4th The International Congress on the Immune Consequences of Trauma, Shock and Sepsis (edited by Faist E), Monduzzi Editore, Bologna, 1997.pp.431-434.

P.62 掲載の参考文献

• 1) Nagai H, Henrich H, Fischbach W, et al:Role of pancreatic enzyme and thier substrates in autidigestion of the pancreas. In vitro studies with isolated rat pancreatic acini. Gastroenterology 96:838-847, 1989.

• 2) Havel RJ:Pathogenesis, differentiation and management of hyperlipidemia. Adv. Intern. Med. 15:117-154, 1969.
  pubmed

• 3) Takeda S, Morita Y, Yoshikawa T, et al:K. Lipid peroxidation contributes to pancreatic acinar cell injury induced by unsaturated free fatty acids. Gastroenterology 106:A325, 1994.

• 4) 牧野淳子:アミラーゼマルトオリゴ糖を用いた enzyme coupling. Med. Technol. 12:149, 1984.

• 5) Vogel CW and Zieve L:A rapid and sensitive turbidimetric method for serum lipase based upon differences between the lipase of normal and pancreatitis serum. Clin. Chem. 9:168-179, 1963.

• 6) Allain CC:Enzymatic determination of total serum cholesterol. Clin. Chem. 21:470-475, 1974.

• 7) Abe R, Shimosegawa T, Kimura K, et al:The role of endogenous glucocorticoids in rat experimental model of acute pancreatitis. Gastroenterology 109:933-943, 1995.
  pubmed

P.66 掲載の参考文献

• 1) Morris DC and Jacobs DM:Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13:813-818, 1976.

• 2) Aoki H, Kodama M, Tani T, et al:Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am. J. Surg. 167:412-417, 1994.
  pubmed

• 3) Yow EM and Moyer JH:Toxicity of polymyxin B. Arch. Intern. Med. 92:248-257,1953.
  pubmed

• 4) Endo S, Inada K, Kikuchi M, et al:Clinical effects of intramuscular administration of a small dose of polymyxin B to patients with endotoxemia. Res. Commun. Chem. Pathol. Pharmacol. 83:223-235, 1994.
  pubmed

• 5) Aono K, Isobe K, Nakashima I, et al:Kupffer cells cytotoxicity against hepatoma cells is related to nitric oxide. Biochem. Biophys. Res. Commun. 201:1175-1181, 1994.
  pubmed

• 6) Mayumi T, Takezawa J, Takahashi H, et al:A small dose of intramuscular polymyxin B improves survival of septic rat. (submitted)

• 7) Munster AM, Winchurch RA, Thupari JN, et al:Reversal of postburn immunosuppression with low-dose polymyxin B. J. Trauma 26:995-998, 1986.
  pubmed

• 8) Bender BS, Winchurch RA, Thupari JN, et al:Depressed natural killer cell function in thermally injured adults:successful in vivo and in vitro immunomodulation and the role of endotoxin. Clin. Exp. Immunol. 71:120-125, 1988.
  pubmed

• 9) Yao YM, Tian HM, Sheng ZY, et al:Inhibitory effects of low-dose polymyxin B on hemorrhage-induced endotoxin bacterial translocation and cytokine formation in rats. J . Trauma 38:924-930, 1995.
  pubmed

P.70 掲載の参考文献

• 1) Dinarello C:The proinflammatory cytokines inter-leukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J. Infect. Dis.113:1177-1184, 1991.

• 2) Repine j, Cheronis T, Rodell T, et al:Pulmonary oxygen toxicity and ischemia reperfusion injury. Am. Rev. Respir. Dis. 136:483-485, 1987.

• 3) Flaherty J and Weisfeldt M:Reperfusion injury. Free Radical Biol. Med. 5:409-419, 1988.
  pubmed

• 4) Colletti L, Remick D, Burtch G, et al:Role or tumor necrosis factor-α in the pathophysiologic alternations after hepatic ischemic/reperfusion injury in the rat. J. Clin. Invest. 85:1936-1943, 1990.

• 5) Koga S, Ogawa S, Kuwabara K, et al:Synthesis and release of interleukin 1 by reoxygenated human mononuclear phagocytes. J. Cline. Invest. 90:1007-1015, 1992.

• 6) Bevilacqua MP, Pober JS, Mendrick DL, et al:Identification of an incredible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA 84:9238-9242, 1987.

• 7) Shreeniwas R, Koga S, Karakurum M, et al:Hypoxia-mediated induction of endothelial cell interleukin-la. J. Clin. Invest. 90:2333-2339, 1992.

• 8) Wakabayashi G, Gelfand JA, Jung WK, et al:Staphylococcus epidermis induces complement activation. Tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia:Comparison to Escherichia coli. J. Clin. Invest. 87:1925-1935, 1991.

• 9) Shirasugi N, Wakabayashi G, Shimazu M, et al:IL-1 up-regulates oxygen free radicals production in the liver with ischemia-reperfusion injury. Lymphokine Cytokine Res. 12:393a, 1993.

• 10) Humphreys M and Hopkins S:Simple sensitive and specific bioassay of interleukin-1. J. Immunol. Methods. 120:271-276,1 989.

P.74 掲載の参考文献

• 1) Ardlie NG, McGuiness JA and Garrett JJ:Effect on human platelets of catecholamines at levels achieved in the circulation. Atherosclerosis 58:251-259, 1985.
  pubmed

• 2) Larsson PT, Wallen NH and Hjemdahl P:Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 89:1951-1957, 1994.
  pubmed

• 3) deBlois D, Schwartz SM, van Kleef EM, et al:Chronic a1 adrenoreceptor stimuration increases DNA synthesis in rat arterial wall:Modulation of responsiveness after vascular injury. Arterioscler. Thromb. Vasc. Biol. 16:1122-1129, 1996.

• 4) Nyrop M and Zweifler AJ:Platelet aggregation in hypertension and the effects of antihypertensive treatment. J. Hypertens. 6:263-269, 1988.
  pubmed

• 5) Hernandez RH, Carvajal AR, Pajuelo JG, et al:The effect or doxazosin on platelet aggregation in normotensive subjects and patients with hypertension:An in vitro study. Am. Heart J. 121:389-394, 1991.

• 6) Myers MG, Norris JW, Hachinski VC, et al:Plasma norepinephrine in stroke. Stroke 12:200-204, 1981.

• 7) 諸岡 弘, 大本堯史:脳卒中急性期脳微小循環障害におけるRadical生成と交感神経の役割. 脳虚血とフリーラジカル (佐野圭司, 高倉公明, 小暮久也・編), にゅーろん社, 東京, 1983, pp.189-199.

• 8) Goldstein DS, Eisenhofer G, Stull R, et al:Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J. Clin. Invest. 81:213-220, 1988.
  pubmed

• 9) Tofler GH, Brezinski D, Schafer AL, et al:Concurrent morning increase in platelet aggregability and risk of myocardial infarction and sudden cardiac death. N. Engl. J. Med. 316:1514-1518, 1987.

• 10) 諸岡 弘:脳梗塞再発予防に対する最適抗血小板薬の検討. Cyto-protection & biology 14:67-70, 1996.

P.78 掲載の参考文献

• 1) Zimmerman UP and Sclaepher WW:Calcium- activated neutral protease (CANP) in brain and other tissues. Prog. Neurobiol. 23:63-78, 1984.

• 2) Saido TC, Nagao S, Shiramine M, et al:Autolytic transition of a-calpain upon activation as resolved by antibodies distinguishing between the pre-and post-autolysis forms. J. Biochem. 111:81-86, 1992.
  pubmed

• 3) Langendorff O:Untersuchungen am uberlebenden Saugethierherzen. Arch. Ges. Physiol. 61:291-332, 1895.

• 4) Spencer MJ and Tidball JG:Calpain concentration is elevated although net calcium-dependent proteolysis is suppressed in dystrophin-deficient muscle. Exp. Cel. Res. 203:107-114, 1992.

• 5) 鵜飼知彦:心筋虚血および再灌流障害におけるカルシウム依存性システインプロテアーゼ(カルパイン)の動態解析. 名市大医誌 47(2):155-168, 1996.

• 6) Yoshida K, Inui M, Harada K, et al:Reperfusion of Rat Heart After Brief Ischemia Induces Proteolysis of Calspectin (Nonerythroid Spectrin or Fodrin) by Calpain. Circ. Res. 77:603-610, 1995.
  pubmed